Skip to main content
Premium Trial:

Request an Annual Quote

Asuragen Quantidex Pan Cancer Kit

Asuragen has launched the Quantidex Pan Cancer Kit, a next-generation sequencing oncology panel of 21 genes relevant to a diverse set of human cancers. The kit integrates reagents, controls, and a novel bioinformatics suite and is optimized to interrogate difficult sample types such as formalin-fixed, paraffin-embedded and fine-needle aspiration tissues, Asuragen said. More specifically, the kit contains reagents for pre-analytical DNA QC, sample quantification, multiplex PCR enrichment, dual-index barcoding, and library purification and quantification, the company said. The product is currently for research use only, Asuragen noted.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.